CAPZA, an established European private investment platform focused on small and mid-cap companies, has participated in the refinancing of Sterimed Group’s debt, a specialist in the medical sterilisation packaging industry, and is supporting the acquisition of the European hospital packaging division of the listed group Amcor.
Founded in 1911, Sterimed is one of the world’s leading manufacturers of medical sterilisation packaging. Sterimed develops, produces, converts and markets various types of ready-to-use packaging solutions for both hospitals and medical device manufacturers. Today, the group benefits from a global footprint with a broad industrial and commercial base.
Positioned in a market with strong structural growth, Sterimed continues to strengthen its downstream value chain by acquiring the European hospital packaging manufacturing and distribution business of the Amcor group. This activity, which includes a manufacturing site in France and two sales offices in Spain and Germany, has total sales of approximately EUR42 million. With this acquisition, Sterimed is expanding its converting business and broadening its product range for hospitals and medical device manufacturers in Europe and worldwide.
Including this new activity, Sterimed now has more than 1,100 employees and has nine industrial sites and 22 sales offices on all continents, generating approximately EUR200 million in revenue.
In the context of this acquisition and of the refinancing of Sterimed’s debt, CAPZA arranged a PIK bond financing on top of a senior financing arranged by the group’s banks for a total leverage of around four times the Ebitda.
“This acquisition is in line with Sterimed’s vertical integration strategy, which has been successfully led by its high quality management team. We are delighted to support Sterimed, a major player in its sector, in its development ambitions,” says Guillaume de Jongh, Partner CAPZA.
